BIM
ANAC

BlackRock Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlackRock Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-216,460
Closed -$11.6M – 4296
2016
Q1 		$11.6M Buy
216,460
+32,642
+18% +$2.41M 0.02% 850
2015
Q4 		$20.8M Buy
183,818
+3,810
+2% +$420K 0.03% 550
2015
Q3 		$21.2M Buy
180,008
+29,913
+20% +$3.91M 0.03% 523
2015
Q2 		$11.6M Buy
150,095
+34,175
+29% +$2.24M 0.01% 911
2015
Q1 		$6.71M Buy
115,920
+1,596
+1% +$67.8K 0.01% 1186
2014
Q4 		$3.69M Buy
114,324
+10,232
+10% +$307K ﹤0.01% 1595
2014
Q3 		$2.55M Buy
104,092
+872
+0.8% +$17.7K ﹤0.01% 1820
2014
Q2 		$1.83M Buy
103,220
+32,975
+47% +$531K ﹤0.01% 2145
2014
Q1 		$1.41M Buy
70,245
+672
+1% +$13K ﹤0.01% 2272
2013
Q4 		$1.17M Sell
69,573
-2,332
-3% -$32.3K ﹤0.01% 2402
2013
Q3 		$764K Buy
71,905
+5,888
+9% +$51.5K ﹤0.01% 2638
2013
Q2 		$369K Buy
+66,017
New +$400K ﹤0.01% 3013

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlackRock Investment Management's ANAC Position: Q2 2016 in Review

BlackRock Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 216,460 shares — an estimated $11.6M sold.

BlackRock Investment Management first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $21.2M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • BlackRock Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • BlackRock Investment Management sold 216,460 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $11.6M.
  • BlackRock Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • BlackRock Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $21.2M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlackRock Investment Management's 13F filing for Q2 2016, filed 10 Aug 2016.